Illustration of the Disulfide bond formulation in the vaccine.

Illustration of the Disulfide bond formulation in the vaccine.

<p>(A) The vaccine preliminary 3-D structure; (B) Represents the modified vaccine design (based on disulfide bonds formulation); small yellow rods show bond creation.</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Saurav Kumar Mishra (13228369) (author)
مؤلفون آخرون: Kanishka Sithira Senathilake (20797077) (author), Neeraj Kumar (109718) (author), Chirag N. Patel (4722756) (author), Mohammad Borhan Uddin (20797080) (author), Taha Alqahtani (12855941) (author), Ali Alqahtani (7039244) (author), Hanan M. Alharbi (17357516) (author), John J. Georrge (4722759) (author)
منشور في: 2025
الموضوعات:
Medicine
Microbiology
Molecular Biology
Biotechnology
Immunology
Infectious Diseases
Virology
Biological Sciences not elsewhere classified
severe health issue
prospective physiochemical characteristics
mol binding energy
immunological evaluation demonstrated
igm +&# 8201
identified one b
human immunodeficiency virus
conjoined concurrently using
284 amino acids
1 envelope glycoprotein
strong molecular interaction
gpgpg ), including
epitope subunit vaccine
developed vaccine stimulates
designed vaccine expression
robust immune response
immune response
aids ),
specific vaccine
immune reaction
widespread pandemic
viroinformatics approach
tlr3 shows
tertiary structures
specific linker
research sought
putative epitopes
protective potency
pet28a (+))
overall investigation
multiple epitopes
md simulation
laboratory analysis
ii epitopes
hiv );
gc content
four mhc
exploratory algorithms
examining hiv
eight mhc
docking analysis
devise multi
cell interaction
c terminal
assisted screening
100ns ).
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
الوصف
الملخص:<p>(A) The vaccine preliminary 3-D structure; (B) Represents the modified vaccine design (based on disulfide bonds formulation); small yellow rods show bond creation.</p>

مواد مشابهة